Get Drugs Payment Scheme Application Form

You may be able to reduce the cost of your contraception through the Drug Payment Scheme. For example, the cost of long-acting reversible contraceptives such as the IUS (hormonal coil) or IUD (copper coil). You may also be able to claim tax relief on medical expenses.

You may be able to reduce the cost of your contraception through the Drug Payment Scheme. For example, the cost of long-acting reversible contraceptives such as the IUS (hormonal coil) or IUD (copper coil). You may also be able to claim tax relief on medical expenses.

Birth control is considered to be preventive care, and therefore it has to be covered without copays or deductibles. In other words, when you go to pick up your birth control pills, you shouldn't have to pay anything at the pharmacy. Or when you go to get your IUD, you shouldn't have to pay anything out of pocket.

(Saxenda®) 6 mg/ml solution for injection in pre-filled pen is available for reimbursement under the Community Drug Schemes (CDS), specifically the Drugs Payment (DP) and General Medical Services (GMS) schemes from 1st January 2023.

You can submit a request for coverage with the help of your health care provider. Just print out this sample letter that he or she can use as the basis for a note on their own letterhead. Then bring it to your benefits or human resources manager.

With a Saxenda® Savings Card, you can pay as little as $25 or save up to $200 per Saxenda® prescription. Eligibility and other terms apply.

The HSE has approved reimbursement for (Saxenda®) 6 mg/ml solution for injection in pre-filled pen under the community drug schemes from 1st January 2023. This product is approved for reimbursement on the basis of managed access.

The list price for both is around $1,350 a month, which means the same drug is 51 percent more expensive if it is used to treat obesity over diabetes. Most payers do not cover Saxenda or Wegovy because they are weight-loss drugs.

The HSE advise that reimbursement for Semaglutide (Ozempic®) is confined to those with eligibility under the General Medical Services Scheme (GMS) or the Long-Term Illness (LTI) scheme. This medicine is not available on the Drugs Payment Scheme.